Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × NSCLC × Cryotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 12 Warts 11 Breast Neoplasms 11 Uterine Cervical Dysplasia 7 Retinoblastoma 6 Prostatic Neoplasms 6 Peripheral Nervous System Diseases 6 Pain 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Neoplasms 5 Stomatitis 4 Pancreatic Neoplasms 3 Mucositis 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Multiple Myeloma 2 Mesothelioma 2 Melanoma 2 Keratosis 2 Condylomata Acuminata 2 Carcinoma, Ductal, Breast 2 Carcinoma, Basal Cell 2 Bone Neoplasms 2 Barrett Esophagus 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1

Interventions

Pemetrexed 14 Carboplatin 12 osimertinib 10 Drug Therapy 9 aflutinib 8 Gefitinib 7 Radiotherapy 6 Docetaxel 6 Cisplatin 6 anlotinib 5 Radiosurgery 5 pembrolizumab 4 Vinorelbine 4 Paclitaxel 4 Gemcitabine 4 tislelizumab 3 icotinib 3 apatinib 3 HM781-36B 3 Erlotinib Hydrochloride 3 toripalimab 2 spartalizumab 2 rezivertinib 2 camrelizumab 2 Tyrosine Kinase Inhibitors 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2 Platinum 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07530744 2026-04-15

Cronos

Elisabethinen Hospital

Phase NA Not yet recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡